Results for untargeted MS search on m/z: (+/-) mode
| Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| AN000870 | 7-hydroxy-5-heptynoic acid | 0.84 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Benzenamine sulfate | 0.85 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | N-Acetylputrescine | 0.87 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Azaserine | 0.89 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | DL-?-Lipoic Acid | 0.89 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Lysine | 0.89 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | C7 N O6 S | 0.89 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | C4 N O4 S | 0.89 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | 2-Iodophenol | 0.89 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | 3-(Pyrazol-1-yl)-L-alanine | 0.92 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | 5,7,4'-Trihydroxyflavanone 7-sulfate | 0.92 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | L-Arginine | 0.92 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | 3-Methyl-L-histidine | 0.92 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Valdecoxib | 0.93 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | edetate | 0.94 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | AMPA | 0.94 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | 5,7,3',5'-Tetrahydroxy-3,6,8,4'-tetramethoxyflavone 3'-glucoside | 0.94 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | 5-Methylcytidine | 0.94 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Cetraxate | 0.94 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | (+)-12a-Hydroxyerythynone | 0.95 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Senecivernine | 0.95 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Desmethylmianserin glucuronide | 0.96 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | 3-Butynoate | 0.96 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | 5-Formiminotetrahydrofolic acid | 0.96 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | 1,6-Anhydro-?-D-glucose | 0.96 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | (E)-2-Methylglutaconic acid | 0.96 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | b-Glucose | 0.96 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Phe Phe Thr | 0.96 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Levobunolol glucuronide | 0.96 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Myxothiazol Z | 0.96 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Quinaprilat | 0.97 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Gly Pro | 0.97 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | N2-Succinylglutamic acid | 0.97 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | HBA | 0.97 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Tetrahydropalmatine | 0.98 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | 2-Amino-3-methyl-1-butanol | 0.98 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | L-Valine | 0.99 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Urea | 0.99 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | 2-Oxo-10-methylthiodecanoic acid | 1.02 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | 3-Pyridylacetic acid | 1.02 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | N6-Acetyl-N6-hydroxy-L-lysine | 1.02 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Isobutyronitrile | 1.05 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Trp Phe | 1.06 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Creatinine | 1.06 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | 6-methyltetrahydropterin | 1.08 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Tiletamine | 1.09 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Heptanoic acid, 2-amino-, (R)-; (R)-2-Aminoheptanoic acid | 1.09 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Symmetric Dimethylarginine | 1.13 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | S-(2-Methylpropionyl)-dihydrolipoamide-E | 1.2 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | 2S-amino-3-oxo-butanoic acid | 1.33 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | 2-oxo-3-methylvaleric acid | 1.34 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Uridine | 1.34 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | DL-2-Aminooctanoic acid | 1.38 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Uric acid | 1.39 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | DL-pipecolic acid | 1.41 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | THTC | 1.41 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | L-Glutamic acid n-butyl ester | 1.41 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | 4-Oxoproline | 1.41 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | 1-Methyladenosine | 1.41 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Caproic acid | 1.47 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | L-Glutamic acid n-butyl ester + 1.5990624 | 1.6 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | 1-L-Leucyl-L-Proline | 1.63 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Caproic acid + 1.6348685 | 1.63 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | DL-?-Leucine | 2.29 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | N-Hydroxymethylnicotinamide | 2.9 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | N,N-Diethylglycine | 3.64 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Diethyl Oxalpropionate | 3.73 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | o-Methyldopamine (3-methoxytyramine) | 3.92 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Phe Gly Trp | 3.98 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Indoleacrylic acid | 3.98 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Lys Asn Pro | 4.57 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | 3-O-Methyl-myo-inositol | 4.6 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | AFMK | 4.72 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Hippuric acid | 4.74 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Celiprolol | 4.8 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Ursodeoxycholic acid 3-sulfate | 5.17 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Trans-2, 3, 4-Trimethoxycinnamate | 5.8 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | L-Glutamic acid dibutyl ester | 5.83 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Corey PG-Lactone Diol | 6.63 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Corey PG-Lactone Diol + 6.739769 | 6.74 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Metipranolol | 7.32 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | 10-Deoxymethynolide | 8.18 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | 13S-hydroperoxy-9Z,11E,14Z-octadecatrienoic acid | 8.69 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | 8E-Heptadecenedioic acid | 8.76 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Mycalamide A | 9.15 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | methyl-10-hydroperoxy-8E,12Z,15Z-octadecatrienoate | 9.34 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | C17 Sphinganine | 9.64 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Tetrahydrocorticosterone | 9.88 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | N-palmitoyl serine | 10.02 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | cis-Caryophyllene | 10.35 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | N-Oleoyl-L-Serine | 10.55 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | 3-Isochromanone | 10.63 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Scyphostatin A | 10.71 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | LysoPE(0:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 10.87 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Glycerophospho-N-Arachidonoyl Ethanolamine | 10.92 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | 3'-Methoxy-E,E-dienoestrol | 11.05 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Fexofenadine | 11.1 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | Allodeoxycholic Acid | 11.75 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | (Z)-N-(2-hydroxyethyl)hexadec-7-enamide | 12 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | 3?,11?-Dihydroxy-12-oxo-5?-cholan-24-oic Acid | 12.9 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | 3-ketosphingosine | 13.05 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000870 | PE(21:0/20:1(11Z)) | 14.66 | Minutes | ST000566 | POSITIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood |
